Dose-finding based on multiple toxicities in a soft tissue sarcoma trial

Journal of the American Statistical Association

Volumn 99, Issue 465, 2004, Pages 26-35

  Bekele, B Nebiyou ^a   Thall, Peter F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adaptive design; Bayesian inference; Latent variable; Markov chain Monte Carlo

Indexed keywords

EID: 2142670647     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1198/016214504000000043     Document Type: Article

References (11)

1. Albert, J. H., and Chib, S., (1993), “Bayesian Analysis of Binary and Polytomous Response Data,” Journal of the American Statistical Association, 88, 669–679.
2. Babb, J., Rogatko, A., and Zacks, S. (1998), “Cancer Phase I Clinical Trials: Efficient Dose Escalation With Overdose Control,” Statistics in Medicine, 17, 1103–1120.
3. Chen, M. H., and Dey, D. K. (2000), “Bayesian Analysis for Correlated Ordinal Data Models,” in Generalized Linear Models: A Bayesian Perspective, eds. D. K. Dey, S. K. Ghosh, and B. K. Mallick, New York: Marcel Dekker, pp. 133–157.
4. Chib, S., and Greenberg, E. (1998), “Analysis of Multivariate Probit Models,” Biometrika, 85, 347–361.
5. Cowles, M. K. (1996), “Accelerating Monte Carlo Markov Chain Convergence for Cumulative-Link Generalized Linear Models,” Statistics and Computing, 6, 101–111.
6. Durham, S. D., and Fluornoy, N. (1994), “Random Walks for Quantile Estimation,” in Statistical Decision Theory and Related Topics, eds. S. Gupta and J. O. Berger, New York: Springer-Verlag, pp. 467–476.
7. Gasparini, M., and Eisele, J. (2000), “A Curve-Free Method for Phase I Clinical Trials,” Biometrics, 56, 609–615; corr. 57, 659–660.
8. Kruskal, W. (1958), “Ordinal Measures of Association,” Journal of the American Statistical Association, 53, 814–861.
9. O’Quigley, J., Pepe, M., and Fisher, L. (1990), “Continual Reassessment Method: A Practical Design for Phase I Clinical Trials in Cancer,” Biometrics, 46, 33–48.
10. Piantadosi, S., Fisher, J. D., and Grossman, S. (1998), “Practical Implementation of a Modified Continual Reassessment Method for Dose-Finding Trials,” Cancer Chemotherapy and Pharmacology, 41, 429–436.
11. Storer, B. E. (1989), “Design and Analysis of Phase I Clinical Trials,” Biometrics 45, 925–937.